Collaborate Disseminate
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term effects of exposure to sulfur mustard, commonly called ‘musta… Continue reading World-first treatment to prevent long-term eye damage from mustard gas
T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way to give them extra “batteries” to keep them fighting longer, with promising early results in mice.Continue ReadingCategory: Can… Continue reading Giving T cells extra batteries supercharges them against cancer
A 67-year-old London man with lung cancer has been the first to receive a new cancer vaccine as part of an international trial. The early-stage research will test the immune therapy’s safety and whether it can be used together with existing cancer trea… Continue reading First lung cancer vaccine given to patient in international trial
One dose of a new treatment, delivered by nasal spray, clears away build-ups of the toxic tau protein associated with Alzheimer’s disease from inside brain cells, improving memory, according to new research. It paves the way for new treatments for the debilitating disease.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Immunotherapy, antibodies, University of Texas
Continue reading One-dose nasal spray clears toxic Alzheimer’s proteins to improve memory
For the first time, scientists have successfully created a type of mouse with a 100% functional human immune system and human-like gut microbiome. This ‘humanized’ mouse takes the guesswork out of medical research and has the potential to revolutionize… Continue reading ‘Super-humanized’ mice with 100% human immune systems are a big deal
Prostate cancer needs testosterone to grow. In metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease, the cancer continues growing despite a reduction in testosterone brought about by chemical or surgical castration. … Continue reading FDA fast-tracks personalized therapy for hard-to-treat-prostate cancer
Around 29 million people in the US take a daily dose of aspirin as a preventative measure for cardiovascular disease. And while an age-related increased risk of bleeding has seen it fall out of favor with medical authorities, it’s now shaping up as som… Continue reading How aspirin stops the growth and spread of colorectal cancer
Giving an immunotherapy drug as soon as possible after diagnosis with Crohn’s disease significantly reduces complications, including the need for surgery by a factor of 10, a clinical study has found. Compared to conventional treatment, which favors de… Continue reading 79% of Crohn’s disease patients in remission after early intervention
A new form of immunotherapy helps immune cells “armor” themselves against exhaustion by releasing their own medicine to keep them going in the fight against cancer. In a small ongoing trial, 100% of patients have achieved complete remission, and the ne… Continue reading “Armored” immune cells make their own medicine to keep fighting cancer
Following a trail of evidence that started with a study of fruit flies nearly 25 years ago, researchers have found adding a hyperactive form of the protein Rac2 to macrophages, immune cells that eat pathogens, causes them to cannibalize T cells. The no… Continue reading Cannibalistic cells could provide an edge in future cancer treatments